Role of androgen and estrogen receptors for the action of dehydroepiandrosterone (DHEA).

Dehydroepiandrosterone (DHEA) is an abundant steroid hormone, and its mechanism of action is yet to be determined. The aim of this study was to elucidate the importance of androgen receptors (ARs) and estrogen receptors (ERs) for DHEA function. Orchidectomized C57BL/6 mice were treated with DHEA, DHT, 17β-estradiol-3-benzoate (E2), or vehicle. Orchidectomized AR-deficient (ARKO) mice and wild-type (WT) littermates were treated with DHEA or vehicle for 2.5 weeks. At termination, bone mineral density (BMD) was evaluated, thymus and seminal vesicles were weighted, and submandibular glands (SMGs) were histologically examined. To evaluate the in vivo ER activation of the classical estrogen signaling pathway, estrogen response element reporter mice were treated with DHEA, DHT, E2, or vehicle, and a reporter gene was investigated in different sex steroid-sensitive organs after 24 hours. DHEA treatment increased trabecular BMD and thymic atrophy in both WT and ARKO mice. In WT mice, DHEA induced enlargement of glands in the SMGs, whereas this effect was absent in ARKO mice. Furthermore, DHEA was able to induce activation of classical estrogen signaling in bone, thymus, and seminal vesicles but not in the SMGs. In summary, the DHEA effects on trabecular BMD and thymus do not require signaling via AR and DHEA can activate the classical estrogen signaling in these organs. In contrast, DHEA induction of gland size in the SMGs is dependent on AR and does not involve classical estrogen signaling. Thus, both ERs and ARs are involved in mediating the effects of DHEA in an organ-dependent manner.

[1]  K. Korach,et al.  Estrogen Receptor-α Mediates Diethylstilbestrol-Induced Feminization of the Seminal Vesicle in Male Mice , 2012, Environmental health perspectives.

[2]  A. Traish,et al.  Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. , 2011, The journal of sexual medicine.

[3]  Shufang Wu,et al.  DHEA suppresses longitudinal bone growth by acting directly at growth plate through estrogen receptors. , 2011, Endocrinology.

[4]  J. Gustafsson,et al.  In vivo activation of gene transcription via oestrogen response elements by a raloxifene analogue. , 2009, The Journal of endocrinology.

[5]  C. Ohlsson,et al.  Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. , 2009, The Journal of clinical endocrinology and metabolism.

[6]  Dajin Li,et al.  Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice , 2008, Osteoporosis International.

[7]  M. Lagerquist,et al.  Identification of target cells for the genomic effects of estrogens in bone. , 2007, Endocrinology.

[8]  D. Tindall,et al.  Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. , 2007, Endocrine reviews.

[9]  L. Kjeldsen,et al.  Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome. , 2007, Arthritis and rheumatism.

[10]  Dajin Li,et al.  Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor. , 2007, Journal of molecular endocrinology.

[11]  E. Levin,et al.  Nature of functional estrogen receptors at the plasma membrane. , 2006, Molecular endocrinology.

[12]  S. Boonen,et al.  Relative Impact of Androgen and Estrogen Receptor Activation in the Effects of Androgens on Trabecular and Cortical Bone in Growing Male Mice: A Study in the Androgen Receptor Knockout Mouse Model , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  J. Simard,et al.  Is dehydroepiandrosterone a hormone? , 2005, The Journal of endocrinology.

[14]  H. Wilkinson,et al.  Direct agonist/antagonist functions of dehydroepiandrosterone. , 2005, Endocrinology.

[15]  J. Gustafsson,et al.  Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands , 2005, BMC Immunology.

[16]  J. Lemmen,et al.  Tissue- and time-dependent estrogen receptor activation in estrogen reporter mice. , 2004, Journal of molecular endocrinology.

[17]  Dongmin Liu,et al.  Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor , 2004, Steroids.

[18]  P. Carmeliet,et al.  A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Dana,et al.  Are women with Sjögren's syndrome androgen-deficient? , 2003, The Journal of rheumatology.

[20]  J. Gustafsson,et al.  Differential effects on bone of estrogen receptor α and androgen receptor activation in orchidectomized adult male mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Yanase,et al.  Aromatase in bone: roles of Vitamin D3 and androgens , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  A. Maggi,et al.  In vivo imaging of transcriptionally active estrogen receptors , 2003, Nature Medicine.

[23]  O. Hiort,et al.  Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  C. Heinlein,et al.  The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. , 2002, Molecular endocrinology.

[25]  K. Dahlman-Wright,et al.  Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. , 2002, The Journal of endocrinology.

[26]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[27]  C. Du,et al.  Administration of Dehydroepiandrosterone Suppresses Experimental Allergic Encephalomyelitis in SJL/J Mice , 2001, The Journal of Immunology.

[28]  J. Simard,et al.  DHEA and Its Transformation into Androgens and Estrogens in Peripheral Target Tissues: Intracrinology , 2001, Frontiers in Neuroendocrinology.

[29]  L. Wide,et al.  Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function. , 2001, The Journal of rheumatology.

[30]  W. Kühn‐Velten.  Intracrinology and the local enzymatic control of hormone distribution and metabolism: dehydroepiandrosterone does not just act as a prohormone for androgens and estrogens , 2000, European journal of clinical investigation.

[31]  D. Agard,et al.  Estrogen receptor pathways to AP-1 , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  A. Vandenbark,et al.  Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. , 2000, The Journal of clinical investigation.

[33]  H. Moutsopoulos,et al.  Sjögren's syndrome: autoimmune epithelitis. , 1994, Bailliere's best practice & research. Clinical rheumatology.

[34]  J. Gustafsson,et al.  Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. , 1999, The Journal of clinical investigation.

[35]  K. Nephew,et al.  Studies of dehydroepiandrosterone (DHEA) with the human estrogen receptor in yeast , 1998, Molecular and Cellular Endocrinology.

[36]  F. Labrie.  DHEA as physiological replacement therapy at menopause , 1998, Journal of endocrinological investigation.

[37]  J. Gustafsson,et al.  Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. , 1997, Molecular endocrinology.

[38]  T. Garcia,et al.  Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. , 1997, Nucleic acids research.

[39]  S. Boonen,et al.  Androgens and bone. , 2004, Calcified tissue international.

[40]  E. Engleman,et al.  Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. , 1995, Arthritis and rheumatism.

[41]  Y. Ito,et al.  Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. , 1994, Endocrine reviews.

[42]  E. Gresik.  The granular convoluted tubule (GCT) cell of rodent submandibular glands , 1994, Microscopy research and technique.

[43]  K. Matsumoto,et al.  Maintenance by androgen and thyroid hormone of androgen‐induced convoluted tubular cells in mouse submandibular glands , 1992, The Anatomical Record.

[44]  E. Bernton,et al.  Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. , 1991, Endocrinology.

[45]  M. Beckner,et al.  Dehydroepiandrosterone reduces cancellous bone osteopenia in ovariectomized rats. , 1990, The American journal of physiology.